SCHEMBL4384831

SCHEMBL4384831

Cc1ccc(OC(=O)c2ccccc2Oc2ccccc2)cc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 4/20 0.62
CYP2C9 P11712 4/20 0.62
CYP2C19 P33261 4/20 0.62
CYP3A4 P08684 2/20 0.62
PTK2B Q14289 1/20 0.56
RXFP1 Q9HBX9 1/20 0.56
MAPT P10636 4/20 0.55
NPSR1 Q6W5P4 3/20 0.55
HPGD P15428 2/20 0.55
XBP1 P17861 1/20 0.55
CTNNB1 P35222 1/20 0.54
SMN1; SMN2 Q16637 1/20 0.52
HSD17B10 Q99714 2/20 0.51
ALOX15 P16050 1/20 0.51
KMT2A Q03164 2/20 0.51
ALDH1A1 P00352 2/20 0.51
TSHR P16473 2/20 0.51
GAA P10253 1/20 0.50
SCN1A P35498 1/20 0.50
SCN2A Q99250 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4382990 0.97 CYP1A2 (0.65) CYP1A2CYP2C9CYP2C19CYP3A4PTK2B
SCHEMBL767125 0.90 CTNNB1 (0.65) CYP1A2CYP2C9CYP2C19CYP3A4MAPT
SCHEMBL11692621 0.88 CYP1A2 (0.57) CYP1A2CYP2C9CYP2C19CYP3A4PTK2B
SCHEMBL10983921 0.87 PTK2B (0.66) CYP1A2CYP2C9CYP2C19CYP3A4PTK2B
SCHEMBL4390471 0.86 PTK2B (0.55) CYP1A2CYP2C9CYP2C19CYP3A4PTK2B
SCHEMBL13971012 0.86 PTK2B (0.55) CYP1A2CYP2C9CYP2C19CYP3A4PTK2B
SCHEMBL4389475 0.85 NPSR1 (0.72) CYP1A2CYP2C9CYP2C19CYP3A4PTK2B
SCHEMBL10919302 0.84 CTNNB1 (0.58) CYP1A2CYP2C9CYP2C19CYP3A4MAPT
SCHEMBL432 0.84 MEN1 (0.56) CYP1A2CYP2C9CYP2C19CYP3A4MAPT
SCHEMBL30775034 0.83 HTT (0.59) CYP1A2CYP2C9CYP2C19CYP3A4MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1829854-B1 PROCESS FOR PRODUCING AROMATIC CARBONATE ASAHI KASEI CHEMICALS CORP (JP) 2013-09-04 EP disclosed
US-7629485-B2 Process for producing aromatic carbonate ASAHI KASEI CHEMICALS CORPORATION (JP) 2009-12-08 US disclosed
US-20080177099-A1 Process for Producing Aromatic Carbonate ASAHI KASEI KABUSHIKI KAISHA (JP) 2008-07-24 US disclosed
EP-1829854-A1 PROCESS FOR PRODUCING AROMATIC CARBONATE Asahi Kasei Chemicals Corporation (JP) 2007-09-05 EP disclosed
EP-1016648-B1 PROCESS FOR THE PREPARATION OF AROMATIC CARBONATES ASAHI CHEMICAL IND (JP) 2003-05-14 EP disclosed
US-6262210-B1 TRANSESTERIFYING DIALKYL CARBONATE, ALKYL ARYL CARBONATE OR MIXTURE WITH AROMATIC MONOHYDROXY COMPOUND IN PRESENCE OF METAL CONTAINING CATALYST TO OBTAIN HIGH BOILING POINT REACTION MIXTURE CONTAINING AROMATIC CARBONATE ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) 2001-07-17 US disclosed
EP-1016648-A1 PROCESS FOR THE PREPARATION OF AROMATIC CARBONATES Asahi Kasei Kogyo Kabushiki Kaisha (JP) 2000-07-05 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080177099-A1 Process for Producing Aromatic Carbonate DCLK1, ALK, DCLK3 CYP1A2 342/4885CYP2C9 69/4885CYP2C19 131/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.